Eltrombopag Can Achieve Treatment Free Remission as Upfront Therapy for Patient with Immune Thrombocytopenia

IF 0.5 Q4 HEMATOLOGY Plasmatology Pub Date : 2021-03-01 DOI:10.1177/26348535211002789
Khaldun Obeidat, M. Yassin
{"title":"Eltrombopag Can Achieve Treatment Free Remission as Upfront Therapy for Patient with Immune Thrombocytopenia","authors":"Khaldun Obeidat, M. Yassin","doi":"10.1177/26348535211002789","DOIUrl":null,"url":null,"abstract":"Immune Thrombocytopenic purpura (ITP) is an immune mediated thrombocytopenia caused by autoantibodies directed against platelet antigens which leads to destruction of the platelets by the spleen and inability of the bone marrow to restore normal counts. The main treatment for ITP is immunosuppressive medication and the first line treatment is glucocorticoids, intravenous immune globulin (IVIG) and Intravenous anti-D immune globulin. Here we report a 45-year old lady who was diagnosed with ITP and achieved treatment free remission after with Eltrombopag as upfront.","PeriodicalId":29816,"journal":{"name":"Plasmatology","volume":"30 1","pages":""},"PeriodicalIF":0.5000,"publicationDate":"2021-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Plasmatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/26348535211002789","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 1

Abstract

Immune Thrombocytopenic purpura (ITP) is an immune mediated thrombocytopenia caused by autoantibodies directed against platelet antigens which leads to destruction of the platelets by the spleen and inability of the bone marrow to restore normal counts. The main treatment for ITP is immunosuppressive medication and the first line treatment is glucocorticoids, intravenous immune globulin (IVIG) and Intravenous anti-D immune globulin. Here we report a 45-year old lady who was diagnosed with ITP and achieved treatment free remission after with Eltrombopag as upfront.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
作为免疫性血小板减少症患者的前期治疗,Eltrombopag可以实现无治疗缓解
免疫性血小板减少性紫癜(ITP)是一种免疫介导的血小板减少症,由针对血小板抗原的自身抗体引起,导致脾脏破坏血小板和骨髓无法恢复正常计数。ITP的主要治疗是免疫抑制药物,一线治疗是糖皮质激素、静脉注射免疫球蛋白(IVIG)和静脉注射抗d免疫球蛋白。在这里,我们报告了一位45岁的女性,她被诊断为ITP,并在使用依特隆巴作为前期治疗后获得了无治疗缓解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Plasmatology
Plasmatology HEMATOLOGY-
CiteScore
1.10
自引率
0.00%
发文量
0
期刊最新文献
Management of a Young Patient With High-risk Multiple Myeloma Complicated by Acquired von Willebrand Syndrome: A Diagnostic and Therapeutic Emergency Effects of Tariff on the Management of Blood Products in Fars Province Hospitals Application of a Caprylate/Chromatography Purification Process for Production of a Hepatitis B Immune Globulin from Pooled Human Plasma Characterization of the Components and Functional Properties of a Plasma-Derived Fibrin Sealant A Pilot Study Evaluating the Ex Vivo Effects of Varying Factor VIII Concentration on Clot Kinetics and Architecture in Patients With Haemophilia A
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1